FDA approves Pfizer’s RSV vaccine for older adults

FDA approves Pfizer’s RSV vaccine for older adults

Source: 
Stat
snippet: 

The Food and Drug Administration approved a second vaccine to protect older adults against RSV on Wednesday, giving a green light to Pfizer’s Abrysvo for adults 60 and older.